Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Lymphatic Metastasis 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1

Interventions

Fulvestrant 60 Capecitabine 47 Trastuzumab 46 Letrozole 45 pembrolizumab 42 Carboplatin 41 Paclitaxel 39 Cyclophosphamide 38 ribociclib 37 abemaciclib 36 pertuzumab 34 Blood Specimen Collection 31 Specimen Handling 28 trastuzumab deruxtecan 27 Surveys and Questionnaires 26 Docetaxel 26 Tamoxifen 25 Anastrozole 25 exemestane 24 palbociclib 21 130-nm albumin-bound paclitaxel 21 Magnetic Resonance Spectroscopy 20 Biopsy 19 sacituzumab govitecan 18 eribulin 18 Radiotherapy 18 Gemcitabine 18 olaparib 17 Injections 17 Epirubicin 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Breast Neoplasms × Lymph Node Excision × Clear all

NCT04889924 2026-05-19

ADARNAT

Hospital Universitari de Bellvitge

Phase NA Recruiting

Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡